top of page

Geneovese

At Geneovese, we are pioneering breakthroughs in oncology for a healthier future.​​

Abstract Blue Patterns

Our Vision

Geneovese aims to achieve an improved  therapeutic index through innovative research and cutting-edge solutions. We are committed to advancing healthcare and environmental sustainability while fostering a culture of collaboration and scientific excellence.

Innovation

Cutting-Edge Solutions

Our technologies focus on building oncology therapeutics that have better tolerability, improved tumor selectivity, modularity for quick iteration, and to address pressing global challenges in oncology.  By leveraging advanced methodologies, a deep understanding of therapeutic windows and interdisciplinary approaches, we aim to deliver the most efficacious solutions in the oncology space.​

Geneovese

​

We are a Delaware C-Corporation advancing the controlled release of cancer therapeutics for patients with aggressive, underserved cancers.  A provisional patent assigns IP to the company, and the founder equity is structured for long-term alignment through completed 83(b) elections. We currently operate with a lean, focused model by partnering with CROs. ​

Connecting Science and Innovation
bottom of page